Studies have revealed that C5a, within the tumor, binds to its receptor C5aR1 on myeloid-derived suppressor cells (MDSCs), which, through the recruitment of MDSCs into the tumor microenvironment, further suppresses CD8+ and CD4+ T cell-mediated anti-tumor immune responses, thereby promoting tumor growth 24,25. The gene discussed is CD4; the disease is neoplasm.